RAPPORT DE LA RÉUNION

RAPPORT DE LA RÉUNION 23 European Roadshow - Paris, le 7 septembre 2018 27. Danne T, Bangstad HJ, Deeb L et al. ISPAD Clinical Practice Consensus Guidelines 2014: Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2014:15(Suppl. 20): 115- 34. 28. Laffel LM, Limbert C, Phelan H, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Sick day management in children and adolescents with diabetes. Pediatr Diabetes 2018;19 (Suppl.27):193–204. 29. Guilmin-Crépon S, Carel JC, Schroedt J, et al. How should we assess glycemic variability in type 1 diabetes? Contribution of principal component analysis for interstitial glucose indices in 142 children. Diabetes Technol Ther 2018;20:440-7. 30. Sherr JL, Tauschmann M, Battelino T, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies. Pediatr Diabetes 2018;19(Suppl. 7):302–25. 31. Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes monitoring may be the key. J Pediatr 2004;144: 660-1. 32. Ziegler R, Heidtmann B, Hilgard D, et all. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatric Diabetes 2011;12:11-7. 33. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self- monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 2013;36:2009-14. 34. Vergier et al. Evaluation of Flash Glucose Monitoring after long-term use: pediatric survey. Prim Care Diabetes . 2018; doi: 10.1016/j. pcd.2018.08.004. 35. Rodbard D. Continuous Glucose Monitoring: a review of recent studies demonstrating improved glycemic outcomes. Diabetes Technol Ther 2017;19:S25-37.